Table Info

Table 5.

Number of animals (%) with histological cutaneous lesions in all experimental groups

Histological cutaneous lesions		G1 WT water	G2 HPV water	G3 WT 0.013 g/mL	G4 HPV 0.006 g/mL	G5 HPV 0.008 g/mL	G6 HPV 0.013 g/mL
Ear pavilion lesions
Dysplasia		0(0%)¹	5(100%)	0(0%)	5(100%)	4(80%)	4(80%)
Papilloma		0(0%)	3(50%)	0(0%)	2(40%)	0(0%)	1(20%)
Sebaceous hyperplasia		0(0%)	4(80%)	0(0%)	3(60%)	4(80%)	1(20%)
Inflammatory infiltrate		0(0%)¹	5(100%)	0(0%)²	5(100%)	5(100%)	5(100%)
Congestion		0(0%)¹	5(100%)	0(0%)²	0(0%)	0(0%)	1(20%)
Hyperplasia
Simple	Focal	0(0%)	0(0%)	0(0%)	0(0%)	0(0%)	1(20%)
Simple	Diffuse	0(0%)	0(0%)	0(0%)	0(0%)	1(20%)	(0%)
Papillary	Focal	0(0%)	0(0%)	0(0%)	0(0%)	0(0%)	0(0%)
Papillary	Diffuse	0(0%)	0(0%)	0(0%)	0(0%)	0(0%)	0(0%)
Papillomatosis	Focal	0(0%)	2(40%)	0(0%)	3(60%)	4(80%)	2(40%)
Papillomatosis	Diffuse	0(0%)	2(40%)	0(0%)	1(20%)	0(0%)	0(0%)
Carcinoma
Carcinoma in situ		0(0%)	1(20%)	0(0%)	0(0%)	0(0%)	0(0%)
Small invasive carcinoma		0(0%)	0(0%)	0(0%)	0(0%)	0(0%)	0(0%)
Invasive carcinoma		0(0%)	0(0%)	0(0%)	0(0%)	0(0%)	0(0%)
Chest skin lesions
Dysplasia		0(0%)¹	5(100%)	0(0%)	5(100%)	4(80%)	4(80%)
Sebaceous hyperplasia		0(0%)¹	5(100%)	0(0%)²	5(100%)	4(80%)	5(100%)
Inflammatory infiltrate		0(0%)	4(80%)	0(0%)	4(80%)	3(50%)	3(50%)
Simple	Simple	0(0%)	0(0%)	0(0%)	0(0%)	0(0%)	0(0%)
Simple	Diffuse	0(0%)	0(0%)	0(0%)	0(0%)	0(0%)	1(20%)
Papillary	Diffuse	0(0%)	0(0%)	0(0%)	0(0%)	0(0%)	0(0%)
Papillary	Focal	0(0%)	0(0%)	0(0%)	0(0%)	0(0%)	0(0%)
Papillomatosis	Diffuse	0(0%)	0(0%)	0(0%)	0(0%)	0(0%)	0(0%)
Papillomatosis	Focal	0(0%)	0(0%)	0(0%)	0(0%)	0(0%)	0(0%)
Papiloma	Inverted papiloma	0(0%)	0(0%)	0(0%)	0(0%)	0(0%)	0(0%)
Papiloma	Exophytic papiloma	0(0%)	2(40%)	0(0%)	1(20%)	1(20%)	1(20%)
Carcinoma	Carcinoma in situ	0(0%)	0(0%)	0(0%)	0(0%)	0(0%)	0(0%)
	Small invasive carcinoma	0(0%)	0(0%)	0(0%)	0(0%)	0(0%)	0(0%)
	Invasive carcinoma	0(0%)	0(0%)	0(0%)	0(0%)	0(0%)	0(0%)

¹ Significantly different from the G2 (P < 0.05). ² Significantly different from the G6 (P < 0.05). G1 are wild-type (WT) mice that drink water; G2 are mice with human papillomavirus (HPV) that drank water; G3 are WT that drank daily an aqueous extract of Aloysia citrodora at a concentration of 0.013 g/mL; G4 are mice with HPV that drank daily an aqueous extract of A. citrodora at a concentration of 0.006 g/mL; G5 are mice with HPV that drank daily an aqueous extract of A. citrodora at a concentration of 0.008 g/mL; G6 are mice with HPV that drank daily an aqueous extract of A. citrodora at a concentration of 0.013 g/mL

Declarations

Author contributions

BMF: Conceptualization, Investigation, Writing—original draft. AIFR, MJP, MJN, IG, MMSMB, and CV: Writing—review & editing. HV, CVN, JS, MGS, LG, MID, LB, and LF: Investigation, Writing—review & editing. RM and RMGDC: Writing—review & editing, Supervision. PAO: Conceptualization, Writing—review & editing, Supervision.

Conflicts of interest

The authors declare that they have no conflicts of interest.

Ethical approval

The experimental work was approved by the animal facility of the University of Trás-os-Montes e Alto Douro (UTAD) with the authorization of the Ethics Committee (approval no. 852-e-CITAB-2020_A_1-e- 122 CITAB-2021) and the Portuguese Veterinary Directorate (approval no. 014139).

Consent to participate

Not applicable.

Consent to publication

Not applicable.

Availability of data and materials

The raw data supporting the conclusions of this manuscript will be made available by the authors, without undue reservation, to any qualified researcher.

Funding

Beatriz Medeiros-Fonseca has a Ph.D. grant with number [2020.07675.BD] (https://doi.org/10.54499/2020.07675.BD); Jéssica Silva has a Ph.D. grant with number [2020.07999.BD] (https://doi.org/10.54499/2020.07999.BD); Mónica G. Silva has a Ph.D. grant with number [UI/BD/151320/2021] (https://doi.org/10.54499/UI/BD/151320/2021) financed by FCT (Foundation for Science and Technology) through FSE (European Social Fund). This work is supported by National Funds by FCT-Portuguese under projects: CITAB [UID/04033/2020] (https://doi.org/10.54499/UIDB/04033/2020); CERNAS [UIDB/00681/2020] (https://doi.org/10.54499/UIDB/00681/2020); LEPABE [UIDB/00511/2020] (https://doi.org/10.54499/UIDB/00511/2020) and [UIDP/00511/2020] (https://doi.org/10.54499/UIDP/00511/2020); ALiCE [LA/P/0045/2020] (https://doi.org/10.54499/LA/P/0045/2020); CIMO [UIDB/00690/2020] (https://doi.org/10.54499/UIDB/00690/2020) and [UIDP/00690/2020] (https://doi.org/10.54499/UIDP/00690/2020); SusTEC, [LA/P/0007/2020] (https://doi.org/10.54499/LA/P/0007/2020); by national funds through the FCT/MCTES (PIDDAC). Furthermore, national funding by FCT/P.I., through the institutional scientific employment program contract for Lilian Barros, Maria I. Dias (https://doi.org/10.54499/CEECINST/00016/2018/CP1505/CT0004), Luís Félix (https://doi.org/10.54499/2021.00458.CEECIND/CP1690/CT0001) contract. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Copyright

References

Bahramsoltani R, Rostamiasrabadi P, Shahpiri Z, Marques AM, Rahimi R, Farzaei MH. Aloysia citrodora Paláu (Lemon verbena): A review of phytochemistry and pharmacology. J Ethnopharmacol. 2018;222:34–51. [DOI] [PubMed]

Hawary SE, Yousif M, Motaal AA, Hameed LAE. Composition and Bioactivities of the Essential Oil from Leaves of Lippia citriodora Kunth Cultivated in Egypt. J Biol Act Prod from Nat. 2011;1:112–9. [DOI]

Pascual ME, Slowing K, Carretero E, Sánchez Mata D, Villar A. Lippia: traditional uses, chemistry and pharmacology: a review. J Ethnopharmacol. 2001;76:201–14. [DOI] [PubMed]

Baratta MT, Dorman HJD, Deans SG, Figueiredo AC, Barroso JG, Ruberto G. Antimicrobial and antioxidant properties of some commercial essential oils. Flavour Fragrance J. 1998;13:235–44. [DOI]

Salama Y, Jaradat N, Hattori K, Heissig B. Aloysia Citrodora Essential Oil Inhibits Melanoma Cell Growth and Migration by Targeting HB-EGF-EGFR Signaling. Int J Mol Sci. 2021;22:8151. [DOI] [PubMed] [PMC]

Almeida HHS, Crugeira PJL, Amaral JS, Rodrigues AE, Barreiro MF. Disclosing the potential of Cupressus leylandii A.B. Jacks & Dallim, Eucalyptus globulus Labill., Aloysia citrodora Paláu, and Melissa officinalis L. hydrosols as eco-friendly antimicrobial agents. Nat Prod Bioprospect. 2024;14:1. [DOI] [PubMed] [PMC]

Al-Maharik N, Salama Y, Al-Hajj N, Jaradat N, Jobran NT, Warad I, et al. Chemical composition, anticancer, antimicrobial activity of Aloysia citriodora Palau essential oils from four different locations in Palestine. BMC Complement Med Ther. 2024;24:94. [DOI] [PubMed] [PMC]

Arbeit JM, Münger K, Howley PM, Hanahan D. Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice. J Virol. 1994;68:4358–68. [DOI] [PubMed] [PMC]

Bogani G, Sopracordevole F, Ciavattini A, Vizza E, Vercellini P, Ghezzi F, et al. HPV persistence after cervical surgical excision of high-grade cervical lesions. Cancer Cytopathol. 2024;132:268–9. [DOI] [PubMed]

10.

Bogani G, Sopracordevole F, Ciavattini A, Vizza E, Vercellini P, Giannini A, et al.; Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV); The Investigators of the Italian HPV study group (iHPV study group). Duration of human papillomavirus persistence and its relationship with recurrent cervical dysplasia. Eur J Cancer Prev. 2023;32:525–32. [DOI] [PubMed]

11.

Bogani G, Sopracordevole F, Ciavattini A, Ghelardi A, Vizza E, Vercellini P, et al. HPV-related lesions after hysterectomy for high-grade cervical intraepithelial neoplasia and early-stage cervical cancer: A focus on the potential role of vaccination. Tumori. 2024;110:139–45. [DOI] [PubMed]

12.

Bogani G, Raspagliesi F, Sopracordevole F, Ciavattini A, Ghelardi A, Simoncini T, et al. Assessing the Long-Term Role of Vaccination against HPV after Loop Electrosurgical Excision Procedure (LEEP): A Propensity-Score Matched Comparison. Vaccines (Basel). 2020;8:717. [DOI] [PubMed] [PMC]

13.

Medeiros-Fonseca B, Mestre VF, Colaço B, Pires MJ, Martins T, Gil da Costa RM, et al. Laurus nobilis (laurel) aqueous leaf extract’s toxicological and anti-tumor activities in HPV16-transgenic mice. Food Funct. 2018;9:4419–28. [DOI] [PubMed]

14.

Santos C, Ferreirinha P, Sousa H, Ribeiro J, Bastos MM, Neto T, et al. Ptaquiloside from bracken (Pteridium spp.) inhibits tumour-infiltrating CD8⁺ T cells in HPV-16 transgenic mice. Food Chem Toxicol. 2016;97:277–85. [DOI] [PubMed]

15.

Gil da Costa RM, Aragão S, Moutinho M, Alvarado A, Carmo D, Casaca F, et al. HPV16 induces a wasting syndrome in transgenic mice: Amelioration by dietary polyphenols via NF-κB inhibition. Life Sci. 2017;169:11–9. [DOI] [PubMed]

16.

Bessada SMF, Barreira JCM, Barros L, Ferreira ICFR, Oliveira MBPP. Phenolic profile and antioxidant activity of Coleostephus myconis (L.) Rchb.f.: An underexploited and highly disseminated species. Ind Crops Prod. 2016;89:45–51. [DOI]

17.

Edwards DA. Early androgen stimulation and aggressive behavior in male and female mice. Physiol Behav. 1969;4:333–8. [DOI]

18.

Paiva I, Gil da Costa RM, Ribeiro J, Sousa H, Bastos MM, Faustino-Rocha A, et al. MicroRNA-21 expression and susceptibility to HPV-induced carcinogenesis - role of microenvironment in K14-HPV16 mice model. Life Sci. 2015;128:8–14. [DOI] [PubMed]

19.

Hubrecht RC, Carter E. The 3Rs and Humane Experimental Technique: Implementing Change. Animals (Basel). 2019;9:754. [DOI] [PubMed] [PMC]

20.

Silva-Reis R, Faustino-Rocha AI, Gonçalves M, Castro Ribeiro C, Ferreira T, Ribeiro-Silva C, et al. Refinement of Animal Model of Colorectal Carcinogenesis Through the Definition of Novel Humane Endpoints. Animals (Basel). 2021;11:985. [DOI] [PubMed] [PMC]

21.

Oliveira M, Nascimento-Gonçalves E, Silva J, Oliveira PA, Ferreira R, Antunes L, et al. Implementation of Humane Endpoints in a Urinary Bladder Carcinogenesis Study in Rats. In Vivo. 2017;31:1073–80. [DOI] [PubMed] [PMC]

22.

Forbes D, Blom H, Kostomitsopoulos N, Moore G, Perretta G. Euroguide: On the Accommodation and Care of Animals Used for Experimental and Other Scientific Purposes. London: Royal Society of Medicine Press Ltd; 2007.

23.

Shaposhnikov S, Azqueta A, Henriksson S, Meier S, Gaivão I, Huskisson NH, et al. Twelve-gel slide format optimised for comet assay and fluorescent in situ hybridisation. Toxicol Lett. 2010;195:31–4. [DOI] [PubMed]

24.

Guilherme S, Santos MA, Gaivão I, Pacheco M. DNA and chromosomal damage induced in fish (Anguilla anguilla L.) by aminomethylphosphonic acid (AMPA)--the major environmental breakdown product of glyphosate. Environ Sci Pollut Res Int. 2014;21:8730–9. [DOI] [PubMed]

25.

Collins AR. The comet assay for DNA damage and repair: principles, applications, and limitations. Mol Biotechnol. 2004;26:249–61. [DOI] [PubMed]

26.

Mega C, Vala H, Rodrigues-Santos P, Oliveira J, Teixeira F, Fernandes R, et al. Sitagliptin prevents aggravation of endocrine and exocrine pancreatic damage in the Zucker Diabetic Fatty rat - focus on amelioration of metabolic profile and tissue cytoprotective properties. Diabetol Metab Syndr. 2014;6:42. [DOI] [PubMed] [PMC]

27.

Shackelford C, Long G, Wolf J, Okerberg C, Herbert R. Qualitative and quantitative analysis of nonneoplastic lesions in toxicology studies. Toxicol Pathol. 2002;30:93–6. [DOI] [PubMed]

28.

Mekuria AN, Tura AK, Hagos B, Sisay M, Abdela J, Mishore KM, et al. Anti-Cancer Effects of Lycopene in Animal Models of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Front Pharmacol. 2020;11:1306. [DOI] [PubMed] [PMC]

29.

Taib M, Bouyazza L, Lyoussi B. Acorn Oil: Chemistry and Functionality. J Food Qual. 2020;2020:e8898370. [DOI]

30.

Durak I, Yurtarslanl Z, Canbolat O, Akyol Ö. A methodological approach to superoxide dismutase (SOD) activity assay based on inhibition of nitroblue tetrazolium (NBT) reduction. Clinica Chimica Acta. 1993;214:103–4. [DOI] [PubMed]

31.

Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121–6. [DOI] [PubMed]

32.

Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70:158–69. [PubMed]

33.

Carlberg I, Mannervik B. Glutathione reductase. Methods Enzymol. 1985;113:484–90. [DOI] [PubMed]

34.

Vessey DA, Boyer TD. Differential activation and inhibition of different forms of rat liver glutathione S-transferase by the herbicides 2,4-dichlorophenoxyacetate (2,4-D) and 2,4,5-trichlorophenoxyacetate (2,4,5-T). Toxicol Appl Pharmacol. 1984;73:492–9. [DOI] [PubMed]

35.

Gartaganis SP, Patsoukis NE, Nikolopoulos DK, Georgiou CD. Evidence for oxidative stress in lens epithelial cells in pseudoexfoliation syndrome. Eye (Lond). 2007;21:1406–11. [DOI] [PubMed]

36.

Schieber M, Chandel Navdeep S. ROS Function in Redox Signaling and Oxidative Stress. Curr Biology. 2014;24:R453–62. [DOI] [PubMed] [PMC]

37.

Faridi R, Zahra A, Khan K, Idrees M. Oncogenic potential of Human Papillomavirus (HPV) and its relation with cervical cancer. Virol J. 2011;8:269. [DOI] [PubMed] [PMC]

38.

Mesquita CS, Oliveira R, Bento F, Geraldo D, Rodrigues JV, Marcos JC. Simplified 2,4-dinitrophenylhydrazine spectrophotometric assay for quantification of carbonyls in oxidized proteins. Anal Biochem. 2014;458:69–71. [DOI] [PubMed]

39.

Brianti P, De Flammineis E, Mercuri SR. Review of HPV-related diseases and cancers. New Microbiol. 2017;40:80–5. [PubMed]

40.

Cheah PL, Looi LM. Biology and pathological associations of the human papillomaviruses: a review. Malays J Pathol. 1998;20:1–10. [PubMed]

41.

Aimagambetova G, Azizan A. Epidemiology of HPV Infection and HPV-Related Cancers in Kazakhstan: a Review. Asian Pac J Cancer Prev. 2018;19:1175–80. [DOI] [PubMed] [PMC]

42.

Spence T, Bruce J, Yip KW, Liu FF. HPV Associated Head and Neck Cancer. Cancers (Basel). 2016;8:75. [DOI] [PubMed] [PMC]

43.

Santos C, Vilanova M, Medeiros R, Gil da Costa RM. HPV-transgenic mouse models: Tools for studying the cancer-associated immune response. Virus Res. 2017;235:49–57. [DOI] [PubMed]

44.

Estêvão D, Costa NR, Gil da Costa RM, Medeiros R. Hallmarks of HPV carcinogenesis: The role of E6, E7 and E5 oncoproteins in cellular malignancy. Biochim Biophys Acta Gene Regul Mech. 2019;1862:153–62. [DOI] [PubMed]

45.

Ferreira T, Nascimento-Gonçalves E, Macedo S, Borges I, Gama A, M Gil da Costa R, et al. Toxicological and anti-tumor effects of a linden extract (Tilia platyphyllos Scop.) in a HPV16-transgenic mouse model. Food Funct. 2021;12:4005–14. [DOI] [PubMed]

46.

Santos S, Ferreira T, Almeida J, Pires MJ, Colaço A, Lemos S, et al. Dietary Supplementation with the Red Seaweed Porphyra umbilicalis Protects against DNA Damage and Pre-Malignant Dysplastic Skin Lesions in HPV-Transgenic Mice. Mar Drugs. 2019;17:615. [DOI] [PubMed] [PMC]

47.

Tammar S, Salem N, Aidi Wannes W, Limam H, Bourgou S, Fares N, et al. Chemometric Profiling and Bioactivity of Verbena (Aloysia citrodora) Methanolic Extract from Four Localities in Tunisia. Foods. 2021;10:2912. [DOI] [PubMed] [PMC]

48.

5-CAFFEOYLSHIKIMIC ACID [Internet]. Bethesda (MD): National Center for Advancing Translational Sciences; [cited 2023 Oct 11]. Available from: https://drugs.ncats.io/drug/5U399BD0RZ

49.

Ooi KL, Muhammad TS, Tan ML, Sulaiman SF. Cytotoxic, apoptotic and anti-α-glucosidase activities of 3,4-di-O-caffeoyl quinic acid, an antioxidant isolated from the polyphenolic-rich extract of Elephantopus mollis Kunth. J Ethnopharmacol. 2011;135:685–95. [DOI] [PubMed]

50.

Pettit GR, Numata A, Takemura T, Ode RH, Narula AS, Schmidt JM, et al. Antineoplastic agents, 107. Isolation of acteoside and isoacteoside from Castilleja linariaefolia. J Nat Prod. 1990;53:456–8. [DOI] [PubMed]

51.

Hong M, Chen D, Hong Z, Tang K, Yao Y, Chen L, et al. Ex vivo and in vivo chemoprotective activity and potential mechanism of Martynoside against 5-fluorouracil-induced bone marrow cytotoxicity. Biomed Pharmacother. 2021;138:111501. [DOI] [PubMed]

52.

Patel K, Gadewar M, Tahilyani V, Patel DK. A review on pharmacological and analytical aspects of diosmetin: a concise report. Chin J Integr Med. 2013;19:792–800. [DOI] [PubMed]

53.

Madunić J, Madunić IV, Gajski G, Popić J, Garaj-Vrhovac V. Apigenin: A dietary flavonoid with diverse anticancer properties. Cancer Lett. 2018;413:11–22. [DOI] [PubMed]

54.

Silva SLD, Nascimento AAD, Ribeiro EFB, Ribeiro RB, Alves CM, Santos AMD, et al. Avaliação da toxicidade aguda pré-clínica do extrato metanólico das cascas do caule de Parahancornia amapa (Apocynaceae). Acta Amaz. 2016;46:73–80. Portuguese. [DOI]

55.

Lee YS, Yang WK, Kim HY, Min B, Caturla N, Jones J, et al. Metabolaid^® Combination of Lemon Verbena and Hibiscus Flower Extract Prevents High-Fat Diet-Induced Obesity through AMP-Activated Protein Kinase Activation. Nutrients. 2018;10:1204. [DOI] [PubMed] [PMC]

56.

Zamorano-Ponce E, Fernández J, Vargas G, Rivera P, Carballo MA. Protective activity of cedron (Aloysia triphylla) infusion over genetic damage induced by cisplatin evaluated by the comet assay technique. Toxicol Lett. 2004;152:85–90. [DOI] [PubMed]

57.

Zehra M, Curry JC, Pillai SS, Lakhani HV, Edwards CE, Sodhi K. Elucidating Potential Profibrotic Mechanisms of Emerging Biomarkers for Early Prognosis of Hepatic Fibrosis. Int J Mol Sci. 2020;21:4737. [DOI] [PubMed] [PMC]

58.

Ferreira T, Campos S, Silva MG, Ribeiro R, Santos S, Almeida J, et al. The Cyclooxigenase-2 Inhibitor Parecoxib Prevents Epidermal Dysplasia in HPV16-Transgenic Mice: Efficacy and Safety Observations. Int J Mol Sci. 2019;20:3902. [DOI] [PubMed] [PMC]